Eikelboom JW - Search Results

1

Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes.

Cherian P, Hankey GJ, Eikelboom JW, Thom J, Baker RI, McQuillan A, Staton J, Yi Q. Cherian P, et al. Among authors: eikelboom jw. Stroke. 2003 Sep;34(9):2132-7. doi: 10.1161/01.STR.0000086466.32421.F4. Epub 2003 Aug 7. Stroke. 2003. PMID: 12907813

2

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.

Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S. Eikelboom JW, et al. Circulation. 2002 Apr 9;105(14):1650-5. doi: 10.1161/01.cir.0000013777.21160.07. Circulation. 2002. PMID: 11940542

3

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.

McQuillan A, Eikelboom JW. McQuillan A, et al. Among authors: eikelboom jw. N Engl J Med. 2002 May 16;346(20):1589-90; author reply 1589-90. N Engl J Med. 2002. PMID: 12017164 No abstract available.

4

Recurrent palmar-plantar erythrodysaesthesia following high-dose cytarabine treatment for acute lymphoblastic leukemia.

Crawford JH, Eikelboom JW, McQuillan A. Crawford JH, et al. Among authors: eikelboom jw. Eur J Haematol. 2002 Nov-Dec;69(5-6):315-7. doi: 10.1034/j.1600-0609.2002.02834.x. Eur J Haematol. 2002. PMID: 12460237

5

Protein Z in ischemic stroke and its etiologic subtypes.

McQuillan AM, Eikelboom JW, Hankey GJ, Baker R, Thom J, Staton J, Yi Q, Cole V. McQuillan AM, et al. Among authors: eikelboom jw. Stroke. 2003 Oct;34(10):2415-9. doi: 10.1161/01.STR.0000092124.52084.4B. Epub 2003 Sep 11. Stroke. 2003. PMID: 12970515

6

Venous thromboembolism in travellers: can we identify those at risk?

McQuillan AD, Eikelboom JW, Baker RI. McQuillan AD, et al. Among authors: eikelboom jw. Blood Coagul Fibrinolysis. 2003 Oct;14(7):671-5. doi: 10.1097/01.mbc.0000061374.39736.fb. Blood Coagul Fibrinolysis. 2003. PMID: 14517493

7

Cyclooxygenase-2 inhibitors: are they really atherothrombotic, and if not, why not?

Hankey GJ, Eikelboom JW. Hankey GJ, et al. Among authors: eikelboom jw. Stroke. 2003 Nov;34(11):2736-40. doi: 10.1161/01.STR.0000097301.50041.6E. Epub 2003 Oct 23. Stroke. 2003. PMID: 14576372 Review.

8

Recombinant activated factor VII for the treatment of life-threatening haemorrhage.

Eikelboom JW, Bird R, Blythe D, Coyle L, Gan E, Harvey M, Isbister J, Leahy M, McIlroy D, Rahimpanah F, Ramanthan S, Strasser S, Ward C, Watts A, Towler S, Yi Q. Eikelboom JW, et al. Blood Coagul Fibrinolysis. 2003 Dec;14(8):713-7. doi: 10.1097/00001721-200312000-00004. Blood Coagul Fibrinolysis. 2003. PMID: 14614349

9

Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials.

Quinlan DJ, McQuillan A, Eikelboom JW. Quinlan DJ, et al. Among authors: eikelboom jw. Ann Intern Med. 2004 Feb 3;140(3):175-83. doi: 10.7326/0003-4819-140-3-200402030-00008. Ann Intern Med. 2004. PMID: 14757615

10

Ximelagatran or warfarin for stroke prevention in patients with atrial fibrillation?

Hankey GJ, Klijn CJ, Eikelboom JW. Hankey GJ, et al. Among authors: eikelboom jw. Stroke. 2004 Feb;35(2):389-91. doi: 10.1161/01.STR.0000115528.53718.1B. Stroke. 2004. PMID: 14757889 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

607 results

Search Page

Filters